Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

MARK Reid PHILIPS

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1179-8156; OpenAlex author ID A5067102350; NIH RePORTER profile ID 1888869. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
2
Labs led
1
Collaborators
12
Papers, trials and grants by year

2020: 1 paper, 1 grant · 2021: none · 2022: 1 grant · 2023: none · 2024: 1 paper

Papers 2

  1. UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma. Last author DOI 10.1073/pnas.2401996121↗
  2. Selective Alanine Transporter Utilization Creates a Targetable Metabolic Niche in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-19-0959↗

Grants 2

  1. Role of nonsense mediated RNA decay in pancreatic cancer R01CA211687↗
  2. Isoprenylcysteine Carboxyl Methyltransferase (ICMT) as a Target in NRAS Driven Melanoma - Resubmission - 1 R01CA163489↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenjuan Su · 1 shared paper, 2024 · strength 0.21
  2. Diane M. Simeone · 1 shared paper, 2024 · strength 0.21
  3. Dafna Bar‐Sagi · 1 shared paper, 2020 · strength 0.09
  4. Madeleine M. LaRue · 1 shared paper, 2020 · strength 0.09
  5. Kate E.R. Hollinshead · 1 shared paper, 2020 · strength 0.09
  6. Joel Encarnación-Rosado · 1 shared paper, 2020 · strength 0.09
  7. Huamin Wang · 1 shared paper, 2020 · strength 0.09
  8. João A. Paulo · 1 shared paper, 2020 · strength 0.09
  9. Keisuke Yamamoto · 1 shared paper, 2020 · strength 0.09
  10. Seth J. Parker · 1 shared paper, 2020 · strength 0.09
  11. Alec C. Kimmelman · 1 shared paper, 2020 · strength 0.09
  12. Joseph Douglas Mancias · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.